ID: ALA5219411
Chembl Id: CHEMBL5219411
PubChem CID: 168298442
Max Phase: Preclinical
Molecular Formula: C9H7BrF3NO4S
Molecular Weight: 362.12
Associated Items:
Canonical SMILES: O=C(CS(=O)(=O)O)Nc1cc(Br)cc(C(F)(F)F)c1
Standard InChI: InChI=1S/C9H7BrF3NO4S/c10-6-1-5(9(11,12)13)2-7(3-6)14-8(15)4-19(16,17)18/h1-3H,4H2,(H,14,15)(H,16,17,18)
Standard InChI Key: ZFFZTOJGNWHHSD-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 362.12 | Molecular Weight (Monoisotopic): 360.9231 | AlogP: 2.29 | #Rotatable Bonds: 3 |
| Polar Surface Area: 83.47 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
| #RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: -2.20 | CX Basic pKa: ┄ | CX LogP: 2.06 | CX LogD: -0.32 |
| Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.81 | Np Likeness Score: -1.54 |
| 1. He R, Wang J, Yu ZH, Moyers JS, Michael MD, Durham TB, Cramer JW, Qian Y, Lin A, Wu L, Noinaj N, Barrett DG, Zhang ZY.. (2022) Structure-Based Design of Active-Site-Directed, Highly Potent, Selective, and Orally Bioavailable Low-Molecular-Weight Protein Tyrosine Phosphatase Inhibitors., 65 (20.0): [PMID:36197449] [10.1021/acs.jmedchem.2c01143] |
Source(1):
